COSMOS Pharmaceutical Umsatz, Kennzahlen, Bilanz/GuV

COSMOS Pharmaceutical: Die Aktie (in JPY)

2024202320222021202020192018
308,61300,48292,38342,90270,65242,24222,65
308,61300,48292,37342,89270,65242,24222,64
308,61300,48292,37342,89270,65242,24222,64
60,0050,0040,0035,0027,5025,0022,50
4.659,003.266,003.266,002.277,002.077,001.781,001.781,00

COSMOS Pharmaceutical: Unternehmenskennzahlen (in JPY)

2024202320222021202020192018
12.178,1110.451,029.538,299.172,238.641,647.716,557.045,60
20,5622,0720,8622,2128,5817,7126,34
20,5622,0720,8622,2128,5817,7126,34
0,950,750,660,460,360,580,38
48,5250,0952,4149,9145,4146,0843,45
51,4849,9147,5950,0954,5953,9256,55

COSMOS Pharmaceutical: GuV (in Mio. JPY)

2024202320222021202020192018
964.989,00827.697,00755.414,00726.424,00684.403,00611.137,00557.999,00
16,599,573,996,1411,999,5210,99
170.038,00152.936,00137.553,00132.310,00122.441,00109.826,0099.430,00
11,1811,183,968,0611,4910,4610,07
31.502,0030.129,0029.797,0033.147,0029.094,0024.776,0022.750,00
4,561,11-10,1113,9317,438,912,30
33.719,0032.773,0033.048,0038.596,0030.402,0027.139,0025.167,00
2,89-0,83-14,3726,9512,027,84-2,21
24.454,0023.797,0023.155,0027.156,0021.435,0019.185,0017.633,00
2,762,77-14,7326,6911,738,80-3,20

COSMOS Pharmaceutical: Bilanz (in Mio. JPY)

2024202320222021202020192018
245.533210.334172.993171.201175.103147.794141.718
407,58230,83138,01147,28166,08184,65192,96
231.442211.072190.507170.578145.675126.289108.888
9,6510,7911,6817,0915,3515,9817,02
476.975421.406363.500341.779320.778274.083250.606
13,1915,936,366,5517,049,3711,04

COSMOS Pharmaceutical: sonstige Angaben (in JPY)

2024202320222021202020192018
308,61300,48292,37342,89270,65242,24222,64
2,712,77-14,7326,6911,738,80-3,20
308,61300,48292,37342,89270,65242,24222,64
2,712,77-14,7326,6911,738,80-3,20
60,0050,0040,0035,0027,5025,0022,50
20,0025,0014,2927,2710,0011,1112,50
5.5125.2905.1014.8724.3864.2403.849
4,203,714,7011,083,4410,168,94
Die Daten werden von FactSet zur Verfügung gestellt.
FactSet vereinheitlicht die Rechnungslegungsstandards IFRS und US-GAAP, um Unternehmenszahlen branchen- und länderübergreifend vergleichbar zu machen.